drugset / Trial / NCT00756938
Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will explore the dose-response of losartan as well as the safety and tolerability in children from 6 months to 6 years of age.
Timeline
- Start
- 2009-03-01
- Primary completion
- 2012-08-14
- Completion
- 2012-08-14
Outcome
Missed primary endpoint
paper No dose-response relationship was established by the slope analysis on SBP (P=0.75) or DBP (P=0.64). PMID 24875194 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 0.1 mg/kg | Oral |
| Subject | Losartan | Other / unclassified | 0.3 mg/kg | Oral |
| Subject | Losartan | Other / unclassified | 0.7 mg/kg | Oral |